Nanomedicine-Nanotechnology Biology and Medicine

Scope & Guideline

Advancing Healthcare through Nanotechnology Innovations

Introduction

Delve into the academic richness of Nanomedicine-Nanotechnology Biology and Medicine with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1549-9634
PublisherELSEVIER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2005 to 2024
AbbreviationNANOMED-NANOTECHNOL / Nanomed.-Nanotechnol. Biol. Med.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

Nanomedicine-Nanotechnology Biology and Medicine focuses on the development and application of nanotechnology in medical science. The journal emphasizes innovative therapeutic strategies, diagnostic tools, and detailed examinations of nanomaterials and their interactions within biological systems.
  1. Nanoparticle Development for Drug Delivery:
    Research on the design and synthesis of nanoparticles for targeted drug delivery systems, enhancing the bioavailability and therapeutic efficacy of various drugs.
  2. Nanotechnology in Cancer Treatment:
    Exploration of nanomedicines and their applications in cancer therapy, focusing on mechanisms of action, efficacy, and safety in clinical settings.
  3. Biocompatibility and Safety Assessments:
    Evaluation of the biocompatibility and safety of nanomaterials used in biomedical applications, including toxicity studies and regulatory considerations.
  4. Innovative Diagnostic Techniques:
    Development of nanoparticle-based diagnostic tools and imaging techniques aimed at early disease detection and monitoring, including the use of biosensors and imaging agents.
  5. Theranostic Applications:
    Integration of therapeutic and diagnostic capabilities in nanomedicine, allowing for simultaneous treatment and monitoring of disease progression.
  6. Nanomaterials for Regenerative Medicine:
    Use of nanotechnology in tissue engineering and regenerative medicine, focusing on scaffolds, drug delivery systems, and cellular interactions.
Recent publications highlight several emerging themes and trends within the journal, reflecting advancements in nanotechnology and its applications in medicine. These trends indicate where future research efforts are likely to be concentrated.
  1. Nanoparticle-Enabled Immunotherapy:
    An increasing number of studies focus on the use of nanoparticles to enhance immunotherapy, indicating a growing interest in integrating nanotechnology with immune modulation for cancer treatment.
  2. CRISPR and Gene Editing Technologies:
    Research involving nanoparticles for gene editing applications, particularly CRISPR/Cas9 delivery systems, is on the rise, showcasing the potential of nanotechnology in genetic therapies.
  3. Microfluidics for Nanoparticle Synthesis:
    The application of microfluidic technologies for the synthesis and characterization of nanoparticles is emerging as a significant trend, providing precise control over particle properties and functions.
  4. Extracellular Vesicles as Nanocarriers:
    A growing body of work is exploring the use of extracellular vesicles derived from cells as natural nanocarriers for drug delivery, highlighting advancements in biocompatible and targeted therapies.
  5. Personalized Nanomedicine:
    There is an increasing trend towards personalized approaches in nanomedicine, with research focusing on tailoring nanoparticle formulations based on individual patient profiles and disease characteristics.
  6. Nanotechnology for Chronic Disease Management:
    Emerging studies are increasingly targeting chronic diseases, such as diabetes and cardiovascular conditions, using nanotechnology for improved therapeutic outcomes and monitoring.

Declining or Waning

While the journal continues to explore a wide range of topics, certain areas of research appear to be declining in frequency or prominence. This shift may reflect evolving interests and advancements in the field of nanomedicine.
  1. Traditional Small Molecule Drug Delivery Systems:
    Research focusing on conventional small molecule drug delivery methods is becoming less prevalent, as the field shifts towards more innovative, nanoparticle-based approaches.
  2. Invasive Surgical Techniques:
    The exploration of invasive techniques in conjunction with nanotechnology is waning, with a greater emphasis on non-invasive or minimally invasive approaches using nanomaterials.
  3. Single-Modal Therapies:
    There is a noticeable decline in studies dedicated solely to single-modal therapies, as the field moves towards combination therapies that integrate nanotechnology with immunotherapy or other modalities.
  4. Basic Physicochemical Characterization:
    While foundational studies are important, there is a diminishing focus on basic physicochemical characterization of nanoparticles without direct applications, as researchers prioritize functional and therapeutic outcomes.

Similar Journals

ACS Biomaterials Science & Engineering

Exploring the Boundaries of Biomaterials Research
Publisher: AMER CHEMICAL SOCISSN: 2373-9878Frequency: 12 issues/year

ACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.

ACS Applied Bio Materials

Exploring Breakthroughs at the Intersection of Biology and Materials
Publisher: AMER CHEMICAL SOCISSN: 2576-6422Frequency: 12 issues/year

ACS Applied Bio Materials is a leading academic journal published by the American Chemical Society, focusing on the innovative intersection of bioengineering and materials science. Since its inception in 2018, the journal has established itself as a pivotal platform for disseminating impactful research within the fields of Biochemistry, Biomaterials, Biomedical Engineering, and Chemistry, often ranked in the top tiers of these categories. With an impressive impact factor, it holds a Q2 ranking in both Biochemistry and Biomaterials, and a prestigious Q1 ranking in Biomedical Engineering and miscellaneous Chemistry, underscoring its significance in advancing knowledge and practices across these disciplines. The journal’s editorial commitment to high-quality, peer-reviewed research ensures relevance and rigor, appealing to a diverse audience of researchers, professionals, and students keen to explore breakthroughs in bio-related materials technology. The access options enhance its visibility and reach, allowing for a broader dissemination of studies that drive innovation and collaboration in biotechnology and material sciences. Located in the heart of Washington, DC, ACS Applied Bio Materials serves as a crucial resource for advancing the future of healthcare, engineering, and materials research.

Bioengineering-Basel

Exploring the Future of Bioengineering
Publisher: MDPIISSN: Frequency: 12 issues/year

Bioengineering-Basel, an esteemed journal published by MDPI, stands at the forefront of innovation in the field of bioengineering since its inception in 2014. With an E-ISSN of 2306-5354, this fully Open Access journal based in Switzerland provides a platform for researchers and professionals to disseminate cutting-edge findings across various aspects of bioengineering, including biomaterials, tissue engineering, and biopharmaceuticals. The journal has been recognized with a Q3 ranking in the 2023 Bioengineering category, reflecting its commitment to quality and relevance. By facilitating widespread accessibility to academic knowledge, Bioengineering-Basel aims to foster collaboration and stimulate thought leadership within the global research community, making it an indispensable resource for students, scholars, and industry practitioners alike.

Biomedical Materials

Bridging Biology and Engineering for Medical Breakthroughs.
Publisher: IOP Publishing LtdISSN: 1748-6041Frequency: 6 issues/year

Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.

Nanomedicine

Innovating Healthcare with Cutting-Edge Nanoscience
Publisher: FUTURE MEDICINE LTDISSN: 1743-5889Frequency: 30 issues/year

Nanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.

Bioengineering & Translational Medicine

Transforming Research into Real-World Solutions
Publisher: WILEYISSN: Frequency: 3 issues/year

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.

Cancer Nanotechnology

Empowering Breakthroughs in Cancer Treatment via Nanotechnology
Publisher: SPRINGER WIENISSN: 1868-6958Frequency: 1 issue/year

Cancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.

Progress in Biomedical Engineering

Innovative insights for cutting-edge biomedical breakthroughs.
Publisher: IOP Publishing LtdISSN: Frequency:

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

Nano LIFE

Pioneering advancements in bioengineering and nanomedicine.
Publisher: WORLD SCIENTIFIC PUBL CO PTE LTDISSN: 1793-9844Frequency: 4 issues/year

Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.

Nanotechnology Science and Applications

Leading the Charge in Nanotechnology Research and Applications.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1177-8903Frequency: 1 issue/year

Nanotechnology Science and Applications, published by DOVE MEDICAL PRESS LTD, is a premier open-access journal dedicated to advancing knowledge in the fields of nanoscience and nanotechnology, particularly focusing on their applications in bioengineering, biomedical engineering, and pharmaceutical sciences. Since its inception in 2008, this journal has provided a platform for the dissemination of high-quality research that is rigorously peer-reviewed, ensuring that only the most impactful findings reach a global audience. With an impressive impact factor reflected in its recent categorization in the Q1 tier for Pharmaceutical Science and Q2 for Bioengineering and Nanoscience, it stands as a critical resource for researchers, practitioners, and students eager to explore the cutting-edge innovations within these rapidly evolving disciplines. The journal's commitment to accessibility and its robust indexing in Scopus—ranked highly in its respective categories—reinforces its importance as a leading forum for the exchange of scientific knowledge and the fostering of collaborative research in nanotechnology applications.